Quantitative Analysis of the Activity in Choroidal Neovascularizations after a Single Anti-VEGF Injection: OCT Versus OCT Angiography
- 30 March 2021
- journal article
- research article
- Published by Taylor & Francis in Seminars in Ophthalmology
- Vol. 36 (7) , 573-581
Abstract
To analyze early quantitative changes in the choroidal neovascularization (CNV) area observed with optical coherence tomography angiography (OCTA) after single anti-vascular endothelial growth fact...Keywords
Funding Information
- Scientific Research Project Office of Manisa Celal Bayar University
This publication has 30 references indexed in Scilit:
- CHARACTERIZING THE EFFECT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ON TREATMENT-NAIVE CHOROIDAL NEOVASCULARIZATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHYRetina, 2015
- OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF SUBRETINAL FIBROSIS IN AGE-RELATED MACULAR DEGENERATIONRetina, 2015
- OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF TIME COURSE OF CHOROIDAL NEOVASCULARIZATION IN RESPONSE TO ANTI-ANGIOGENIC TREATMENTRetina, 2015
- OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY VERSUS TRADITIONAL MULTIMODAL IMAGING IN ASSESSING THE ACTIVITY OF EXUDATIVE AGE-RELATED MACULAR DEGENERATIONRetina, 2015
- Neovascular Age-Related Macular Degeneration2015
- Optical Coherence Tomography Angiography of Type 1 Neovascularization in Age-Related Macular DegenerationAmerican Journal of Ophthalmology, 2015
- Optical Coherence Tomography Angiography during Follow-Up: Qualitative and Quantitative Analysis of Mixed Type I and II Choroidal Neovascularization after Vascular Endothelial Growth Factor Trap TherapyOphthalmic Research, 2015
- Optical Coherence Tomography Angiography Signs of Vascular Abnormalization With Antiangiogenic Therapy for Choroidal NeovascularizationAmerican Journal of Ophthalmology, 2015
- OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapyEye, 2015
- An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular DegenerationAmerican Journal of Ophthalmology, 2007